Example: Heart Attack
Search clinical trials for: 68Ga-FAPI-RGD
Total 2493 results
-
NCT00734773WithdrawnLymphoma | Brain and Central Nervous System Tumors | Neurotoxicity
-
NCT05289804CompletedMild Cognitive Impairment | Memory Impairment | Memory Disorders in Old Age
-
NCT03336346CompletedHIV Infections | Contraceptive Usage | Drug Interaction
-
NCT02976727CompletedActinic Dermatosis
-
NCT01204476CompletedLung Carcinoid Tumor | Metastatic Digestive System Neuroendocrine Tumor G1 | Paraganglioma | Pancreatic Polypeptide Tumor | Pancreatic Glucagonoma | Pancreatic Insulinoma | Recurrent Merkel Cell Carcinoma | Somatostatin-Producing Neuroendocrine Tumor | Stage IV Merkel Cell Carcinoma | Recurrent Digestive System Neuroendocrine Tumor G1
-
NCT05172258Active, not recruitingHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Stage IV Hypopharyngeal Carcinoma AJCC v8 | Stage IV Laryngeal Cancer AJCC v8 | Stage IV Lip and Oral Cavity Cancer AJCC v8
-
NCT05169658CompletedMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
-
NCT00103038CompletedMalignant Glioma | Metastatic Malignant Neoplasm in the Brain | Central Nervous System Lymphoma
-
NCT02501759TerminatedProstate Carcinoma | Health Status Unknown
-
NCT00660543Completed
-
-
NCT07150546RecruitingUnresectable Digestive System Neuroendocrine Neoplasm | Unresectable Digestive System Neuroendocrine Tumor G1 | Digestive System Neuroendocrine Tumor | Unresectable Digestive System Neuroendocrine Tumor G2
-
NCT05020600RecruitingFibromyalgia | Central Sensitisation
-
NCT05773274RecruitingMetastatic Digestive System Neuroendocrine Tumor G1 | Unresectable Digestive System Neuroendocrine Tumor G1 | Unresectable Digestive System Neuroendocrine Tumor G2 | Metastatic Digestive System Neuroendocrine Tumor G2
-
NCT03270059RecruitingMetastatic Malignant Neoplasm in the Brain | Central Nervous System Neoplasm | Cranial Nerve Disorder
-
NCT03806530CompletedRestless Legs Syndrome | End Stage Renal Disease
-
NCT07322341Not yet recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell Carcinoma | Recurrent Lung Non-Small Cell Carcinoma
-
NCT02862275Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
-
NCT05411081Active, not recruitingStage IV Renal Cell Cancer AJCC v8 | Metastatic Papillary Renal Cell Carcinoma
-
NCT04071639RecruitingHuntington Disease
-
-
NCT06557733SuspendedFamilial Adenomatous Polyposis | Colorectal Carcinoma
-
NCT01515813Withdrawn
-
NCT01531361CompletedMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | BRAF Gene Mutation
-
NCT04310020Active, not recruitingLung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8
-
NCT05554380SuspendedLocally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
-
NCT03738228CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Stage IB2 Cervical Cancer AJCC v8 | Stage II Cervical Cancer AJCC v8 | Stage IIA Cervical Cancer AJCC v8 | Stage IIA1 Cervical Cancer AJCC v8 | Stage IIA2 Cervical Cancer AJCC v8 | Stage IIB Cervical Cancer AJCC v8 | Stage IIIB Cervical Cancer AJCC v8
-
NCT03600701Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell Carcinoma
-
NCT06409390RecruitingMetastatic Breast Cancer
-
NCT03304587Completed
-
NCT04076371Completed
-
-
NCT00048893TerminatedBreast Neoplasms | Metastases, Neoplasm
-
NCT04334941Active, not recruitingExtensive Stage Lung Small Cell Carcinoma
-
NCT03565367CompletedMalignant Central Nervous System Neoplasm | Metastatic Malignant Neoplasm in the Central Nervous System
-
NCT02359097Completed
-
NCT07388524Not yet recruiting
-
NCT06442475RecruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal Zone Lymphoma | Ann Arbor Stage IV Marginal Zone Lymphoma
-
NCT05564416WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8
-
NCT03513952CompletedAdvanced Bladder Urothelial Carcinoma | Advanced Ureter Urothelial Carcinoma | Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent Ureter Urothelial Carcinoma
-
NCT05286801Active, not recruitingMalignant Solid Neoplasm | Rhabdoid Tumor | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Rhabdoid Tumor | Refractory Rhabdoid Tumor | Epithelioid Sarcoma | Kidney Medullary Carcinoma | Atypical Teratoid/Rhabdoid Tumor | Poorly Differentiated Chordoma
-
NCT07615751Recruiting
-
NCT03554083CompletedClinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
-
NCT00537056CompletedKidney Neoplasms | Carcinoma, Renal Cell | Kidney (Renal Cell) Cancer
-
NCT03768063Active, not recruiting
-
NCT03065387Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | KRAS Gene Mutation | Metastatic Malignant Solid Neoplasm | EGFR Gene Mutation | ERBB2 Gene Amplification | ERBB2 Gene Mutation | EGFR Gene Amplification | ERBB3 Gene Mutation | ERBB4 Gene Mutation
-
NCT00351910Completed
-
NCT02849496Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast Carcinoma
-
NCT00659126TerminatedMetastatic Malignant Neoplasm in the Brain | Primary Brain Neoplasm
-
NCT06495125RecruitingStage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Adenocarcinoma | Refractory Lung Adenocarcinoma
-
NCT06453044RecruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular Lymphoma | Refractory Grade 2 Follicular Lymphoma | Refractory Grade 3a Follicular Lymphoma